Evidence map›Paper›PMID 26651598›Full record

ArticlePsychiatry research. Neuroimaging2016

Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.

Paul E Croarkin, Paul A Nakonezny, Christopher A Wall, Lauren L Murphy, Shirlene M Sampson, Mark A Frye, John D Port

Registry-linked trialAbstract read
In one paragraph

Article in Psychiatry research. Neuroimaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03363919 (Glutamatergic and GABAergic Biomarkers in rTMS for Adolescent Depression), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03363919 nacompletednot on this mapstarted 2018, after this paper: background citation

Glutamatergic and GABAergic Biomarkers in rTMS for Adolescent Depression

TypeinterventionalSponsorMayo ClinicRan2018 to 2023Enrolled47ConditionsMajor Depressive DisorderArmsNeuroStar TMS Therapy® System, NeuroStar XPLOR®
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Using metabolic imaging to investigate neuromodulatory mechanisms of rTMS.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, United States. Electronic address: croarkin.paul@mayo.edu.
Paul A NakoneznyDepartment of Clinical Sciences, Division of Biostatistics, UT Southwestern Medical Center, Dallas, Texas, United States.
Christopher A WallPrairieCare, Rochester, Minnesota, United States.
Lauren L MurphyDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, United States.
Shirlene M SampsonDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, United States.
Mark A FryeDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, United States.
John D PortDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, United States; Department of Radiology, Mayo Clinic, Rochester, Minnesota, United States.
Mayo Clinic · USSouthwestern Medical Center

Funding

The Mayo Clinic Center for Individualized Treatment of Alcohol DependenceP20AA017830 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2010
$2.5M
1H-MR Spectroscopy of Bipolar Depression Before and After Lamotrigine TreatmentR01MH079261 · NIMH · MAYO CLINIC ROCHESTER · PI FRYE, MARK A · 2009 to 2013
$1.2M
Glutamate Probes in Adolescent DepressionK23MH100266 · NIMH · MAYO CLINIC ROCHESTER · PI CROARKIN, PAUL E · 2014 to 2017
$685k
NIAAA NIH HHS P20 AA017830NIAAA NIH HHS P20AA017830NIMH NIH HHS K23 MH100266NIMH NIH HHS K23MH100266NIMH NIH HHS R01 MH079261NIMH NIH HHS R01MH079261
6 · The paper itself

Abstract

Abnormalities in glutamate neurotransmission may have a role in the pathophysiology of adolescent depression. The present pilot study examined changes in cortical glutamine/glutamate ratios in depressed adolescents receiving high-frequency repetitive transcranial magnetic stimulation. Ten adolescents with treatment-refractory major depressive disorder received up to 30 sessions of 10-Hz repetitive transcranial magnetic stimulation at 120% motor threshold with 3000 pulses per session applied to the left dorsolateral prefrontal cortex. Baseline, posttreatment, and 6-month follow-up proton magnetic resonance spectroscopy scans of the anterior cingulate cortex and left dorsolateral prefrontal cortex were collected at 3T with 8-cm(3) voxels. Glutamate metabolites were quantified with 2 distinct proton magnetic resonance spectroscopy sequences in each brain region. After repetitive transcranial magnetic stimulation and at 6 months of follow-up, glutamine/glutamate ratios increased in the anterior cingulate cortex and left dorsolateral prefrontal cortex with both measurements. The increase in the glutamine/glutamate ratio reached statistical significance with the TE-optimized PRESS sequence in the anterior cingulate cortex. Glutamine/glutamate ratios increased in conjunction with depressive symptom improvement. This reached statistical significance with the TE-optimized PRESS sequence in the left dorsolateral prefrontal cortex. High-frequency repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex may modulate glutamate neurochemistry in depressed adolescents.

Indexed as

Synaptic TransmissionAdolescentBrainFemaleFollow-Up StudiesGlutamic AcidGyrus CinguliHumansMajor Depressive DisorderMalePilot ProjectsPrefrontal CortexProspective StudiesProton Magnetic Resonance SpectroscopyTranscranial Magnetic StimulationTreatment OutcomeGlutamic AcidAdolescent depressionGlutamateGlutamineProton magnetic resonance spectroscopyRepetitive transcranial magnetic stimulation

Identifiers

PMID26651598
PMCPMC4716879
OpenAlexW2174033524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.